bcr;file_uuid;batch_number;project_code;disease_code;day_of_dcc_upload;month_of_dcc_upload;year_of_dcc_upload;withdrawn;program;dbgap_registration_code;additional_studies;tissue_source_site;patient_id;bcr_patient_barcode;bcr_patient_uuid;informed_consent_verified;icd_o_3_site;icd_o_3_histology;icd_10;tumor_tissue_site;adenocarcinoma_invasion;histological_type;histological_type_other;tumor_type;anatomic_neoplasm_subdivision;anatomic_neoplasm_subdivision_other;tissue_prospective_collection_indicator;tissue_retrospective_collection_indicator;gender;days_to_birth;race;ethnicity;other_dx;history_of_neoadjuvant_treatment;days_to_initial_pathologic_diagnosis;age_at_initial_pathologic_diagnosis;year_of_initial_pathologic_diagnosis;initial_pathologic_diagnosis_method;init_pathology_dx_method_other;surgery_performed_type;primary_lymph_node_presentation_assessment;lymph_node_examined_count;number_of_lymphnodes_positive_by_he;number_of_lymphnodes_positive_by_ihc;neoplasm_histologic_grade;histologic_grading_tier_category;maximum_tumor_dimension;residual_tumor;system_version;clinical_stage;pathologic_stage;clinical_T;clinical_N;clinical_M;pathologic_T;pathologic_N;pathologic_M;psa_value;days_to_psa;gleason_score;primary_pattern;secondary_pattern;tertiary_pattern;b_symptoms;extranodal_involvement;serum_markers;igcccg_stage;masaoka_stage;vital_status;days_to_last_followup;days_to_death;person_neoplasm_cancer_status;patient_death_reason;source_of_patient_death_reason;tobacco_smoking_history;year_of_tobacco_smoking_onset;stopped_smoking_year;number_pack_years_smoked;alcohol_history_documented;alcoholic_exposure_category;frequency_of_alcohol_consumption;amount_of_alcohol_consumption_per_day;history_of_diabetes;days_to_diabetes_onset;history_of_chronic_pancreatitis;days_to_pancreatitis_onset;family_history_of_cancer;relative_cancer_type;radiation_therapy;postoperative_rx_tx;history_prior_surgery_type_other;primary_therapy_outcome_success;new_tumor_event_after_initial_treatment;days_to_new_tumor_event_after_initial_treatment;new_neoplasm_event_type;new_neoplasm_event_occurrence_anatomic_site;new_neoplasm_occurrence_anatomic_site_text;progression_determined_by;new_tumor_event_additional_surgery_procedure;days_to_new_tumor_event_additional_surgery_procedure;residual_disease_post_new_tumor_event_margin_status;additional_radiation_therapy;additional_pharmaceutical_therapy;day_of_form_completion;month_of_form_completion;year_of_form_completion;vital_status2;days_to_last_followup3;days_to_death4;person_neoplasm_cancer_status5;patient_death_reason6;radiation_therapy7;postoperative_rx_tx8;primary_therapy_outcome_success9;new_tumor_event_after_initial_treatment10;days_to_new_tumor_event_after_initial_treatment11;new_neoplasm_event_type12;new_neoplasm_event_occurrence_anatomic_site13;new_neoplasm_occurrence_anatomic_site_text14;progression_determined_by15;new_tumor_event_additional_surgery_procedure16;days_to_new_tumor_event_additional_surgery_procedure17;residual_disease_post_new_tumor_event_margin_status18;additional_radiation_therapy19;additional_pharmaceutical_therapy20;day_of_form_completion21;month_of_form_completion22;year_of_form_completion23;bcr_followup_barcode;bcr_followup_uuid;followup_case_report_form_submission_reason;lost_follow_up;followup_treatment_success;day_of_form_completion24;month_of_form_completion25;year_of_form_completion26;tx_on_clinical_trial;regimen_number;bcr_drug_barcode;bcr_drug_uuid;total_dose;total_dose_units;prescribed_dose;prescribed_dose_units;number_cycles;days_to_drug_therapy_start;days_to_drug_therapy_end;therapy_type;therapy_type_notes;drug_name;clinical_trail_drug_classification;regimen_indication;regimen_indication_notes;route_of_administration;therapy_ongoing;measure_of_response;radiations
Nationwide Children's Hospital;003B032E-9C21-4D67-908B-C30C05988284;284.63.0;TCGA;PAAD;22;12;2016;FALSO;;;;HZ;A49I;TCGA-HZ-A49I;27286A38-1035-4A22-9EBC-874DF8C49026;YES;C25.0;8500/3;C25.0;Pancreas;YES;Pancreas-Adenocarcinoma Ductal Type;;Primary;Head of Pancreas;;YES;NO;MALE;-28454;WHITE;NOT HISPANIC OR LATINO;No;No;0;77;2012;Tumor resection;;Whipple;YES;9;3;;G2;Four Tier;5;R1;7th;;Stage IIB;;;;T3;N1;MX;;;;;;;;;;;;Alive;0;;WITH TUMOR;;;;;;;NO;;;;;;;;;;;;;;NO;;;;;;;;;;;21;2;2013;Dead;;308;WITH TUMOR;Pancreatic Cancer;YES;YES;Progressive Disease;NO;;;;;;;;;;;29;5;2014;TCGA-HZ-A49I-F60078;F0CA2A19-8345-4490-BCA7-6F847CC73EFA;Scheduled Follow-up Submission;NO;Progressive Disease;29;5;2014;NO;;TCGA-HZ-A49I-D60081;FB71A107-2BC7-4D38-B3D3-499864A3FA74;;;;;;51;86;Chemotherapy;;5-FU;;;;;NO;Clinical Progressive Disease;TCGA-HZ-A49I-R60079 3DCFD42A-166C-4D2B-A133-687CF5A9FE3F 56 93 External 5040 cGy 25 Primary Tumor Field NO Radiographic Progressive Disease 29 5 2014
Nationwide Children's Hospital;02A3EB69-0290-40F0-8B4D-5CAA9C56F576;410.47.0;TCGA;PAAD;22;12;2016;FALSO;;;;2L;AAQI;TCGA-2L-AAQI;A28CFA95-5A99-40F3-928E-7A94F2492D2C;YES;C25.0;8500/3;C25.0;Pancreas;YES;Pancreas-Adenocarcinoma Ductal Type;;Primary;Head of Pancreas;;NO;YES;MALE;-24381;WHITE;;No;No;0;66;2011;Tumor resection;;Whipple;YES;19;6;;G3;Three Tier;4;R1;7th;;Stage IIB;;;;T3;N1;MX;;;;;;;;;;;;Dead;;103;WITH TUMOR;Pancreatic Cancer;Death Certificate;1;;;;YES;None;;;;;YES;-50;NO;;NO;YES;;Progressive Disease;NO;;;;;;;;;;;8;10;2014;Dead;;103;WITH TUMOR;Pancreatic Cancer;NO;YES;Progressive Disease;NO;;;;;;;;;;;29;7;2014;TCGA-2L-AAQI-F62939;95C4CD42-A583-48BE-8E17-A0084AD03BF7;Scheduled Follow-up Submission;NO;Progressive Disease;29;7;2014;NO;;TCGA-2L-AAQI-D62945;BAEB6BC0-C599-4813-86AC-B5EDEA4D74C8;;;;;;42;72;Chemotherapy;;Gemcitabine;;;;;NO;Clinical Progressive Disease;
Nationwide Children's Hospital;05EB6876-15D7-4D39-9E92-A3DE82B313B8;424.46.0;TCGA;PAAD;22;12;2016;FALSO;;;;2J;AABK;TCGA-2J-AABK;C24C54EA-4095-460D-BB53-E3629A56CD62;YES;C25.0;8500/3;C25.0;Pancreas;YES;Pancreas-Adenocarcinoma Ductal Type;;Primary;Other (please specify);Uncinate process;NO;YES;MALE;-26188;WHITE;;No;No;0;71;2012;Tumor resection;;Whipple;YES;19;2;0;G2;Four Tier;2,8;R1;7th;;Stage IIB;;;;T3;N1;M0;;;;;;;;;;;;Alive;484;;TUMOR FREE;;;;;;;NO;;;;NO;;NO;;;;YES;YES;;Complete Remission/Response;NO;;;;;;;;;NO;NO;16;7;2014;Alive;484;;TUMOR FREE;;YES;YES;Complete Remission/Response;NO;;;;;;;;;NO;NO;16;7;2014;TCGA-2J-AABK-F62446;FAB543A3-4959-4A90-A1B6-394CAFE3ED02;Scheduled Follow-up Submission;NO;;5;8;2014;NO;;TCGA-2J-AABK-D63318;ED08197F-DD7E-4060-873F-3D8983DD6A0F;;;;;;;;Chemotherapy;;;;;;;NO;;TCGA-2J-AABK-R63186 8D255F61-2338-42A4-8319-787BC997C31B 44 81 External 5040 cGy 28 Primary Tumor Field NO 4 8 2014